Dennis Ross-Degnan, ScD, MSPH

Harvard Medical School

Harvard Medical School
Phone: (617) 509-9920
Fax: (617) 859-8112


Dennis_Ross-Degnan@hms.harvard.edu

Dennis Ross-Degnan, ScD, MSPH

Harvard Medical School

EDUCATIONAL TITLES

  • Associate Professor, Population Medicine, Harvard Medical School

DF/HCC PROGRAM AFFILIATION

Research Abstract

Dennis Ross-Degnan, ScD, Associate Professor and Harvard Pilgrim Health Care Director of Research, is a health services researcher with a doctorate in health policy and management. He is also co-Director of a World Health Organization Collaborating Center on Pharmaceutical Policy and a member of the Dana Farber-Harvard Cancer Center Risk Reduction Core. He coordinates data management and analyses for the Drug Policy Research Group痴 large database research studies and leads the DPRG痴 qualitative research portfolio. Dr. Ross-Degnan痴 research focuses on the effects of pharmaceutical policies, factors underlying appropriate use of medicines, and interventions to change the practices of health providers. He has developed and tested many behaviorally-focused interventions to improve quality of care and translate clinical best practice to defined populations, both in the United States and in many developing countries. He also leads work on disparities in access to medical care by minority populations.

Publications

Powered by Harvard Catalyst
  • Stout NK, Nekhlyudov L, Li L, Malin ES, Ross-Degnan D, Buist DS, Rosenberg MA, Alfisher M, Fletcher SW. Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011. JAMA Intern Med 2014; 174:114-21. PubMed
  • Simon SR, Zhang F, Soumerai SB, Ensroth A, Bernstein L, Fletcher RH, Ross-Degnan D. Failure of automated telephone outreach with speech recognition to improve colorectal cancer screening: a randomized controlled trial. Arch Intern Med 2010; 170:264-70. PubMed
  • Wharam JF, Galbraith AA, Kleinman KP, Soumerai SB, Ross-Degnan D, Landon BE. Cancer screening before and after switching to a high-deductible health plan. Ann Intern Med 2008; 148:647-55. PubMed
  • Taveras EM, Sandora TJ, Shih MC, Ross-Degnan D, Goldmann DA, Gillman MW. The association of television and video viewing with fast food intake by preschool-age children. Obesity (Silver Spring) 2006; 14:2034-41. PubMed
  • Soumerai SB, Mah C, Zhang F, Adams A, Barton M, Fajtova V, Ross-Degnan D. Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control. Arch Intern Med 2004; 164:645-52. PubMed
  • Ross-Degnan D, Simoni-Wastila L, Brown JS, Gao X, Mah C, Cosler LE, Fanning T, Gallagher P, Salzman C, Shader RI, Inui TS, Soumerai SB. A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population. Int J Psychiatry Med 2004; 34:103-23. PubMed
  • Wagner AK, Soumerai SB, Zhang F, Mah C, Simoni-Wastila L, Cosler L, Fanning T, Gallagher P, Ross-Degnan D. Effects of state surveillance on new post-hospitalization benzodiazepine use. Int J Qual Health Care 2003; 15:423-31. PubMed
  • Madden JM, Soumerai SB, Lieu TA, Mandl KD, Zhang F, Ross-Degnan D,. Effects of a law against early postpartum discharge on newborn follow-up, adverse events, and HMO expenditures. N Engl J Med 2002; 347:2031-8. PubMed
  • Ross-Degnan D. Changing behavior to maintain a healthy home. Pediatr Infect Dis J 2000; 19:S117-9. PubMed
  • Briesacher B, Ross-Degnan D, Adams A, Wagner A, Gurwitz J, Soumerai S. A new measure of medication affordability. Soc Work Public Health 2009; 24:600-12. PubMed